instruction:
Given a paragraph, generate a claim that is supported by the given paragraph. 1) The claim must contain information from within the paragraph. 2) A sentence within the paragraph can be used as a claim. 3) The claim should not have contradictions within the paragraph. 4) The claim should be at most one sentence long.
question:
CES is allowing space for sex tech companies as a one-year trial. At the show, such companies were scattered throughout the health and wellness section, near startups pitching fitness trackers and infrared saunas. Lora DiCarlo, a startup that pushed for changes after organizers revoked its award, showed off its Osé robotic “personal massager.” It’s one of a dozen companies at the show focused on vibrators, lube dispensers and other sex tech products. Founders of these startups say their products are about empowerment and wellness for women, something they say has often been overlooked in tech. The historically male-dominated tech trade show has received criticism in past years for having an all-male lineup of speakers and for previously allowing scantily clad “booth babes,” fostering a “boys’ club” reputation. Besides allowing sex tech, CES organizers brought in an official “equality partner,” The Female Quotient, to help ensure gender diversity. The Female Quotient, which trains companies in equality practices, will hold a conference for women during the four-day show, which opened Tuesday. “It’s been a process,” said Gary Shapiro, the head of the Consumer Technology Association, which puts on CES. It’s been a longer process for many sex tech companies to convince investors that they are part of a growing trend that has enough customers. Much of the push has come from the startups’ female founders and from younger consumers who talk more openly about sexuality. As with other technologies, some exhibitors including Lora DiCarlo had prominent booths at CES, while others such as the wearable vibrator company Crave were tucked away. Crave’s exhibit included a camper with a “Build-a-Vibe-Workshop,” where attendees could get an engraved vibrator to wear around their neck. Sex tech has existed in some form for decades. But the gates really began to open in 2016, said Andrea Barrica, founder of sex education site O.school. That year, several other “fem tech” companies made progress in areas such as menstruation and menopause. Those paved the way for sex tech to grow and get investors interested. “Larger institutions are starting to take note, all the way from VC firms to large Fortune 100 companies,” said Barrica, who recently published the book “Sextech Revolution: The Future of Sexual Wellness.” Large institutions like CES had no choice but to look at sex tech, she said. The journey hasn’t been easy. Sex tech founders, many of them women, recount being turned down by dozens of investors. They faced decency arguments and entrenched corporate standards that equated them with porn. But investors are becoming more receptive, said Cindy Gallop, a former advertising executive turned sex tech entrepreneur and founder of the website MakeLoveNotPorn. “It’s entirely because of our refusal to allow the business world to put us down,” she said. Founders insist that their devices — ranging from vibrators to lube dispensers to accessories — have effects outside the bedroom. “Sexual health and wellness is health and wellness,” said Lora DiCarlo, CEO and founder of the company of the same name. “It does way more than just pleasure. It’s immediately connected to stress relief, to better sleep, to empowerment and confidence.” DiCarlo’s $290 Osé device has gotten $3 million worth of advance sales, bolstered in part by the attention it received after CES organizers overturned a decision by an independent panel of judges to give the vibrator a prestigious Innovation Honoree Award in the robotics and drone category. The organizers, CTA, told the company it reserved the right to rescind awards for devices deemed “immoral, obscene, indecent, profane or not in keeping with CTA’s image.” DiCarlo and other female founders pushed back for banning them but allowing humanoid sex robots meant to serve men the previous year. Following criticism, CES organizers ultimately  reinstated the award and apologized. A few months later, the show announced policy changes such as a dress code to prevent skimpy outfits and new “Innovation for All” sessions with senior diversity officials. Osé began shipping to customers this month. DiCarlo said the company is planning to introduce new devices, including less expensive options. Sex tech companies still face major barriers to growth. Polly Rodriguez, CEO of sexual wellness company Unbound, said the company is profitable and customers are more open about buying products than they once were. But she said she still faces roadblocks advertising on social media, and many traditional investors snub the company. “Things are better, but there’s just still this genuine fear of female sexuality more broadly within the institutional side of technology,” she said. And while Gallop offered to speak at CES, conference organizers declined, saying sex tech was not a part of its conference programming. ___ AP Business Writer Joseph Pisani contributed to this report. ___ AP’s CES coverage: https://apnews.com/Consumerelectronics
answer:
Sex tech from women-led startups pops up at CES gadget show.


question:
"There is no mention of cost. The story could have at least reported what the drug costs in its current use against blood cancer. The story did a good job of explaining both the potential benefits and harms of the drugs. This was a particular strength of this story – and made it stand out in comparison with the LA Times blog story that we also reviewed. Harms were emphasized from the outset – even in the headline – in the AP story but were never mentioned in the LA Times story. And this story reminded readers of the side effects encountered with another MS drug, Tysabri. Outstanding job on this issue by the AP. The story did a very good job of explaining the studies. There is no sign of disease-mongering in this story. Two apparently independent sources were quoted. The story did a good job comparing the new drugs with existing approaches to treat MS. Story explains that the drug is already sold to treat a rare blood cancer and stated that ""it’s too soon to know if the pills will be approved by the government or widely adopted by physicians."" It does not report, however, as the LA TImes blog did, that ""The drug company MD Serono, an affiliate of Merck, has requested approval from the Food and Drug Administration to market the tablet. However it recently received a ""refuse to file"" letter from the FDA, which means the agency is requiring additional information or data. MD Serono said it is pursuing the matter with the FDA and hopes to re-submit its application."" We think that’s a crucial piece of information that affects availability, although, of course, doctors can still prescribe it for off-label use even before the FDA acts on the new request. The novelty of ""tests of the first two oral drugs developed for treating MS"" was clear in the story. It is clear that this story did not rely on a news release."
answer:
MS pills show promise and risk, studies say


question:
"Phony marijuana targeted by recent state legislation sounds worse than the real thing, if you believe Georgia’s governor. Chase’s Law strengthens a ban on ""synthetic marijuana,"" ground-up plant material laced with chemicals that mimic marijuana. Chase Burnett, the bill’s namesake, was found dead in March in a hot tub at his Fayette County home, a packet of the drugs nearby. He was 16. The bill passed with overwhelming support. On March 27, Gov. Nathan Deal signed it into law. A press release warned of synthetic marijuana’s dangers:  ""As the usage has dramatically increased, instances of violence, bodily harm and even death have risen with it,"" it said. We’ve heard that the drug is nasty stuff. But what’s this about violence, bodily harm and death? A Deal spokeswoman sent PolitiFact Georgia news stories and poison control data to prove the governor’s point. We also talked to researchers and law enforcement officials and reviewed news stories and scientific studies. The form of synthetic marijuana that’s sparking so much concern is sold at head shops and gas stations under brand names such as ""Spice"" and ""K2."" Georgia made it a felony to manufacture and sell it in 2010. Chase’s Law tries to keep underground chemists from tweaking their recipes to get around state restrictions. There’s little scholarly research on the drug, which appears to be new to the U.S.  Federal labs first detected these drugs in November 2008, according to the Drug Enforcement Administration. The earliest U.S. news story we found about its rising popularity appeared in a Hutchinson  Kan., newspaper in November 2009. All signs suggest that synthetic marijuana use is increasing dramatically, but data is in short supply. Workers at the American Association of Poison Control Centers began tracking synthetic marijuana calls in 2010 after they noticed more inquiries, a spokeswoman told PolitiFact Georgia. In 2010, they received 2,906  calls; in 2011, there were 6,959. About 11 percent of high school seniors reported using synthetic marijuana in the past year, according to 2011 results of an annual survey by the National Institute on Drug Abuse. It was the first time researchers asked about the drug. Existing data support Deal’s claim that reports of bodily harm have climbed. Georgia Poison Center call data show 10 users were admitted to a hospital’s critical care unit in 2010 after using the drug. Forty-five were admitted in 2011. Rapid heartbeat, agitation, drowsiness, vomiting, hallucinations and nausea were among the drug’s most common effects, researchers have found. Media accounts report drug users injured in car crashes, falls and other accidents -- some fatal. Whether synthetic marijuana is directly responsible for deaths -- and whether they’re increasing -- is a more complicated issue. We found no published studies on the drug’s lethality, but there have been ""scattered reports of deaths,"" said Lloyd Johnston, a University of Michigan professor who conducted the National Institute on Drug Abuse survey. A count of news stories suggests there are more deadly cases. But whether the drug is a direct cause or contributing factor is not clear in some instances. Consider Burnett’s death. Toxicology tests are still in the works. Whether the official cause of death was drowning, the drug or something else is unsettled. Georgia Bureau of Investigation spokesman John Bankhead told PolitiFact Georgia of two other recent deaths: We found other accounts of synthetic marijuana-related deaths. For example, a South Carolina coroner ruled that it was directly responsible for the October death of a college basketball player who collapsed during warm-up, according to multiple news accounts. PolitiFact Georgia found less support for Deal’s claim about violence. We found no published studies on the subject. News stories, however, suggest there’s cause for concern. For instance: To sum up:  Evidence supports Deal’s claim that use of the drug has ""dramatically increased,"" as has synthetic marijuana-related ""bodily harm."" Some evidence suggests that deaths have risen, too. The link between the drug and violence is less clear. News accounts suggest there is an increase in both, but we found so few cases it’s hard to tell. Deal’s statement could use clarification. Still, it earns a ."
answer:

As the usage [of synthetic marijuana] has dramatically increased, instances of violence, bodily harm and even death have risen with it.